Mitesco, Inc. Amends 8-K Filing
Ticker: MITI · Form: 8-K/A · Filed: Sep 24, 2025 · CIK: 802257
Sentiment: neutral
Topics: amendment, equity-securities, financial-statements
TL;DR
Mitesco filed an amendment to its 8-K, updating info on stock sales and financials.
AI Summary
Mitesco, Inc. filed an amendment (8-K/A) on September 24, 2025, to its Form 8-K dated September 18, 2025. The amendment pertains to unregistered sales of equity securities and other events, including financial statements and exhibits. The filing indicates a change in reporting related to these items.
Why It Matters
This amendment provides updated or corrected information regarding Mitesco's financial status and equity transactions, which is crucial for investors to make informed decisions.
Risk Assessment
Risk Level: medium — Amendments to SEC filings can indicate previously undisclosed information or corrections, potentially impacting the company's financial standing or regulatory compliance.
Key Players & Entities
- Mitesco, Inc. (company) — Registrant
- September 18, 2025 (date) — Earliest event reported date
- September 24, 2025 (date) — Filing date of amendment
- Nevada (jurisdiction) — State of incorporation
FAQ
What specific event triggered the original Form 8-K filing on September 18, 2025?
The filing indicates 'Unregistered Sales of Equity Securities' and 'Other Events' as items of disclosure for the original Form 8-K.
What is the purpose of this 8-K/A filing?
This filing is an amendment to a previously filed Form 8-K, suggesting updates or corrections to the information originally reported.
When was Mitesco, Inc. incorporated?
Mitesco, Inc. is incorporated in Nevada.
What are the former names of Mitesco, Inc. listed in the filing?
The filing lists former names including True Nature Holding, Inc., Trunity Holdings, Inc., and BRAIN TREE INTERNATIONAL INC.
What is the business address and phone number provided for Mitesco, Inc.?
The business address is 505 Beachland Blvd., Suite 1377, Vero Beach, FL 32963, and the business phone number is 844-383-8689.
Filing Stats: 1,098 words · 4 min read · ~4 pages · Grade level 12.9 · Accepted 2025-09-23 21:04:32
Key Financial Figures
- $1,052,575 — eferred stock whose total face value is $1,052,575, and which bears interest at 10% annual
- $25 — Preferred Stock") whose stated value is $25 per share. The Series A Shares may be c
- $4.00 — n stock by dividing the stated value by $4.00 (the "Conversion Price"). The Series A
- $257,700 — al of 2,025,910 shares in redemption of $257,700 of its Series A Preferred Stock during
- $13,591,200 — es of the Series A Preferred shares, is $13,591,200. The Company is in discussions with the
Filing Documents
- miti8ka1092325.htm (8-K/A) — 32KB
- mitiex99-1.htm (EX-99.1) — 17KB
- 0001185185-25-001273.txt ( ) — 214KB
- miti-20250918.xsd (EX-101.SCH) — 3KB
- miti-20250918_lab.xml (EX-101.LAB) — 33KB
- miti-20250918_pre.xml (EX-101.PRE) — 22KB
- miti8ka1092325_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2025 MITESCO, INC. (Exact Name of Registrant as Specified in Charter) Nevada 000-53601 87-0496850 (State or another jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 505 Beachland Blvd. , Suite 1377 Vero Beach , Florida 32963 (Address of principal executive offices) (Zip Code) ( 844 ) 383-8689 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None Title of each class Trading Symbol(s) Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 3.02 Unregistered Sales of Equity Securities. The Company issued these shares to accredited Institutional investors in a transaction not involving a public offering pursuant to section 4(a)(2) of the United States Securities Act of 1933, as amended. Series X Preferred Stock dividend payments in Q3 FY2025 The Company has 42,103 shares of its Series X Preferred stock whose total face value is $1,052,575, and which bears interest at 10% annually. The interest can be paid through the issuance of restricted common stock priced using the closing price per share on the 15 th of each month. The Company has issued a total of 99,338 shares of restricted common stock for the payment of its dividends on its Series X Preferred shares for Q3 FY2025. The issuances were as follows: Leath – 8,787 shares, Balencic – 8,787 shares, Mitchell – 8,787, Clifton – 2,941shares, Anglo Irish – 70,035 shares. Series A Preferred Stock redemptions during Q3 FY2025 As a part of its FY2024 Restructuring Plan the Company issued to certain holders of its notes and other securities a newly created a new Series A Amortizing Convertible Preferred Stock (the "Series A Shares" or "Series A Preferred Stock") whose stated value is $25 per share. The Series A Shares may be converted into shares of common stock by dividing the stated value by $4.00 (the "Conversion Price"). The Series A Shares may be converted at the option of the holder at any time, or mandatorily by the Company if certain conditions set forth in the certificate of designation are met. As stipulated in the certificate of designation, unless converted, shares of Series A Preferred Stock will be redeemed by the Company, using common stock, or cash, 1/36 th of the remaining amounts monthly beginning in January 2025. The cash redemption shall be 105% of the original price of the Series A Preferred Stock (as adjusted) and common stock redemption shall be at a 10% discount to the average of the five lowest closing prices over a 30-trading day period. The Company intends to accrue the redemption shares monthly and issue any shares to be used thereunder quarterly to reduce its expense. Each of the holders has agreed not to hold at any point in time more than 4.9% of the Company's common stock, which has served to reduce the rate of redemption for the Series X Preferred shares. The Company issued a total of 2,025,910 shares in redemption of $257,700 of its Series A Preferred Stock during Q3. The issuances were as follows: Pinz Capital – 150,849 shares, GS Capital – 330,000 shares (reduced from allowable to stay under 5% in total holdings), Jefferson Street – 95,062 shares, AJB – 725,000 shares (reduced from allowable to stay under 5% in total holdings), Cavalry/Mercer/CM – 725,000 shares in aggregate (reduced from allowable to stay under 5% total holdings). These issuances resulted in the reduction of Series A Preferred stock of $257,700, and the remaining outstanding value, after giving effect to these issuances of the Series A Preferred shares, is $13,591,200. The Company is in discussions with the holders o